Phentermine Over the Counter Alternative 2026 – OTC Appetite Suppressant Search Trend Analysis Positions PhenQ as a Market Leader According to 1200 Doctors 
Caring Heart Placement Announces Expanded Senior Care Advisory Initiatives in Scottsdale, Arizona
SCOTTSDALE, AZ, Jan. 01, 2026 (GLOBE NEWSWIRE) -- Caring Heart Placement today announced the expansion of its senior care advisory...
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
Creation of new Executive Vice President role integrating Global Communications and Investor Relations to strengthen strategic messaging and stakeholder alignment...
The World’s First Belt-Type Sensing Wearable Device
A Next-Generation Non-Invasive Healthcare Device to Be Unveiled at CES 2026 (Las Vegas)NAGOYA, Japan, Jan. 1, 2026 /PRNewswire/ -- D.O.N...
Therap Services Enhances Care Quality through Integrated Health Tracking and Comprehensive Reporting
TORRINGTON, Conn., Jan. 1, 2026 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic documentation solutions for organizations in...
Bebird Launches EarSight Ultra X: The 5G-Powered Ear Care Solution for Modern Families Pursuing a Quality Life
Next-Generation Device Combines Unprecedented Visual Clarity with Enhanced Safety for Proactive Family WellnessNEW YORK, Jan. 1, 2026 /PRNewswire/ -- Bebird,...
MasterClass Launches a Class on Dopamine to Help Members Balance Pleasure and Pain in an Overloaded World
Stanford addiction psychiatrist and bestselling author teaches members how to reset their brain's reward system and feel in control in...
Immortal Dragons Comments on Longevity Regulation and Investment Trends Following FT Podcast Appearance
SINGAPORE, Jan. 1, 2026 /PRNewswire/ -- Boyang Wang, founder of Singapore-based longevity investment firm Immortal Dragons, has issued a public...
ChemPartner Unveils Updated Visual Identity and Digital Experience Reflecting Its Reputation as a Trusted Biopharma Partner
ChemPartner's new visual language embodies decades of scientific rigor, adaptive and scalable partnership, and a commitment to visionary life science...
START 2026 STRONG WITH PLANET FITNESS
Now through January 9, save $28 or more when you join for just $1 down and only $15 a monthHAMPTON,...
Life Line Screening (Updated): What You Need to Know?
New York City,, Jan. 01, 2026 (GLOBE NEWSWIRE) -- in 2026, The greatest way to stay healthy and avoid illnesses...
Heal N Soothe (Updated): Does It Work For Chronic Pain?
New York City,, Jan. 01, 2026 (GLOBE NEWSWIRE) -- In 2026, Millions of people suffer from chronic back and joint...
Best Keto Gummies for 2026: BHB Supplement Guide Examines What Consumers Should Know Before Buying
Revra Keto BHB Gummies highlighted among ketogenic supplements as independent analysis examines full spectrum BHB formulations, exogenous ketone research, consumer...
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update
Clinical Data doubles known genetic factors associated with urate and GoutCALGARY, Alberta, Dec. 31, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics...
Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical...
LuluTox Detox Tea Unveiled: Why Lulutox Tea Being Discussed as the Best Herbal Weight Loss Tea Blend for Women to Burn Fat in 2026
Discover Lulutox Detox Tea, a herbal blend designed to support digestion, detox balance, and daily wellness. Ingredients, usage, and availability...
Alvotech Secures Term Loan Facility of USD 100 Million
USD 100 million senior term loan facility with a 2-year maturityStrengthens liquidity to support execution across Alvotech’s R&D pipeline and...
Alvotech Secures Term Loan Facility of USD 100 Million
USD 100 million senior term loan facility with a 2-year maturityStrengthens liquidity to support execution across Alvotech’s R&D pipeline and...
Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
FDA issues Complete Response Letter (CRL) for resubmitted ONS-5010 BLAISELIN, N.J., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc....
Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE...
River Oaks Treatment Center Offers Expanded Mental Health Services as the New Year Brings Increased Focus on Wellness
RIVERVIEW, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- The start of a new year often brings reflection, resolve, and the...